C. STOCKHOLDERS EQUITY (Tables)

3 Months Ended

Dec. 31, 2016

C. Stockholders Equity Tables

Stock options, stock bonuses and compensation granted by the Company

Stock options, stock bonuses and compensation granted by the Company as of December 31, 2016 are as follows:

Name of Plan	Total Shares Reserved Under Plans		Shares Reserved for Outstanding Options		Shares Issued		Remaining Options/Shares Under Plans
Incentive Stock Options Plans		3,460,000		1,648,966		N/A		1,511,334
Non-Qualified Stock Option Plans		9,680,000		6,563,284		N/A		2,389,098
Stock Bonus Plans		5,594,000		N/A		4,003,926		1,589,247
Stock Compensation Plan		3,350,000		N/A		2,087,257		1,229,692
Incentive Stock Bonus Plan		16,000,000		N/A		15,600,000		400,000

Stock options, stock bonuses and compensation granted by the Company as of September 30, 2016 are as follows:

Name of Plan	Total Shares Reserved Under Plans		Shares Reserved for Outstanding Options		Shares Issued		Remaining Options/Shares Under Plans
Incentive Stock Option Plans		3,460,000		1,648,966		N/A		1,511,334
Non-Qualified Stock Option Plans		9,680,000		6,940,321		N/A		2,059,261
Bonus Plans		5,594,000		N/A		3,161,211		2,431,962
Stock Compensation Plan		3,350,000		N/A		1,985,037		1,331,912
Incentive Stock Bonus Plan		16,000,000		N/A		15,600,000		400,000

Stock option activity:

	Three Months Ended December 31,
	2016		2015
Granted		-		-
Expired		377,037		-
Forfeited		-		22,966

Schedule of employees and non-employees stock compensation

Stock-Based Compensation Expense

	Three months Ended December 31,
	2016		2015
Employees	$	312,375	$	427,910
Non-employees	$	78,553	$	329,195

Derivative Liabilities, Warrants and Other Options

The following chart presents the outstanding warrants and non-employee options, listed by expiration date at December 31, 2016:

Warrant	Issue Date	Shares Issuable upon Exercise of Warrant		Exercise Price		Expiration Date	Reference
Series P	2/10/12		590,001	$	4.50	3/6/17
Series DD	12/8/16		34,024,000	$	0.18	6/8/17		1
Series EE	12/8/16		34,024,000	$	0.18	9/8/17		1
Series N	8/18/08		2,844,627	$	0.53	8/18/17
Series U	4/17/14		445,514	$	1.75	10/17/17		1
Series S	10/11/13 -10/24/14		25,928,010		1.25	10/11/18		1
Series V	5/28/15		20,253,164	$	0.79	5/28/20		1
Series W	10/28/15		17,223,248	$	0.67	10/28/20		1
Series X	1/13/16		3,000,000	$	0.37	1/13/21
Series Y	2/15/16		650,000	$	0.48	2/15/21
Series Z	5/23/16		6,600,000	$	0.55	11/23/21		1
Series ZZ	5/23/16		500,000	$	0.55	5/18/21		1
Series BB	8/26/16		400,000	$	0.55	8/22/21		1
Series FF	12/8/16		1,701,200	$	0.16	12/1/21		1
Series CC	12/8/16		17,012,000	$	0.20	12/8/21		1
Series AA	8/26/16		5,000,000	$	0.55	2/22/22		1
Consultants	3/6/12- 7/1/16		575,000	$	0.37- $3.50	3/5/17- 6/30/19		2

Tabular disclosure of derivative liabilities at fair value

The table below presents the warrant liabilities and their respective balances at the balance sheet dates:

	December 31, 2016		September 30, 2016
Series S warrants	$	490,040	$	3,111,361
Series U warrants		-		-
Series V warrants		202,532		1,620,253
Series W warrants		132,254		1,799,858
Series Z warrants		101,817		970,604
Series ZZ warrants		6,725		70,609
Series AA warrants		84,092		763,661
Series BB warrants		5,916		58,588
Series CC warrants		455,931		-
Series DD warrants		72,353		-
Series EE warrants		176,804		-
Series FF warrants		54,242		-
Total warrant liabilities	$	1,782,706	$	8,394,934

Schedule Of Gains and (Losses) on Derivative Liabilities

The table below presents the gains on the warrant liabilities for the three months ended December 31:

	2016		2015
Series S warrants	$	2,621,321	$	2,826,153
Series U warrants		-		31,186
Series V warrants		1,417,721		3,240,506
Series W warrants		1,667,604		2,025,115
Series Z warrants		868,787		-
Series ZZ warrants		63,884		-
Series AA warrants		679,569		-
Series BB warrants		52,672		-
Series CC warrants		604,492		-
Series DD warrants		370,919		-
Series EE warrants		514,603		-
Series FF warrants		66,740		-
Net gain on warrant liabilities	$	8,928,312	$	8,122,960